The Broach Foundation funds the clinical and translational research of Dr. Frederick Lang and his colleagues in the Brain Tumor Center at The University of Texas MD Anderson Cancer Center.

The funding provided by The Broach Foundation has allowed the Lang Laboratory to make significant preclinical progress toward developing new treatments for brain tumors, particularly glioblastoma (GBM), for which there is currently no cure.

Dr. Lang’s research focuses on biological therapies, naturally occurring viruses, cells, or molecules, whose intrinsic properties can be exploited for treating brain tumors. Dr. Lang and his team of scientists have used state-of-the-art techniques to “reprogram” these biological agents to effectively kill brain cancers. Donations from The Broach Foundation have helped to fund promising clinical trials for next-generation treatments and have expedited groundbreaking discoveries - from the use of Delta-24-RGD, a common cold virus, as one of the first effective immunotherapies for brain tumors, to delivering Delta-24-RGD via Mesenchymal Stem Cells, to treatment with microRNAs as a potentially new paradigm for GBM therapy.

With clinical trials ongoing and treatments awaiting FDA approval, the Lang Laboratory is working tirelessly to find a cure for brain cancer. For research updates, please sign up for our mailing list and click here to learn more about the Lang Laboratory at MD Anderson Cancer Center.